# Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer

> **NCT00387348** · PHASE3 · TERMINATED · sponsor: **Massachusetts General Hospital** · enrollment: 24 (actual)

## Conditions studied

- Colorectal Cancer
- Depression
- Esophageal Cancer
- Extrahepatic Bile Duct Cancer
- Fatigue
- Gallbladder Cancer
- Gastric Cancer
- Liver Cancer
- Lung Cancer
- Pancreatic Cancer

## Interventions

- **DRUG:** escitalopram oxalate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00387348
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-03
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 24 (ACTUAL)
- **Why stopped:** DSMB stopped study because placebo arm had more adverse events
- **Last updated:** 2012-12-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00387348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00387348, "Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00387348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*